Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk
- PMID: 19684995
- PMCID: PMC6619276
- DOI: 10.4104/pcrj.2009.00054
Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk
Abstract
Primary care spirometry services can be provided by trained primary care staff, peripatetic specialist services, or through referral to hospital-based or laboratory spirometry. The first of these options is the focus of this Standards Document. It aims to provide detailed information for clinicians, managers and healthcare commissioners on the key areas of quality required for diagnostic spirometry in primary care--including training requirements and quality assurance. These proposals and recommendations are designed to raise the standard of spirometry and respiratory diagnosis in primary care and to provide the impetus for debate, improvement and maintenance of quality for diagnostic (rather than screening) spirometry performed in primary care. This document should therefore challenge current performance and should constitute an aspirational guide for delivery of this service.
Conflict of interest statement
MLL has accepted sponsorship for attending conferences from, has accepted lecture fees from, or has been on advisory boards or provided consultancy for, the following companies; GlaxoSmithKline (GSK), AstraZeneca (AZ), Chiesi, Merck Sharpe and Dohme (MSD), Merck, Altana Pharma, Novartis, MEDA Pharmaceuticals, 3M Pharmaceuticals, Schering Plough, Boehringer Ingelheim (BI), Alk-Abello and Ranbaxy. He is the Editor-in-Chief of the PCRJ, but was not involved in the editorial review of, nor the decision to publish, this article. PQ: no declared conflict of interest. RB: no declared conflict of interest. BC: no declared conflict of interest
SH has accepted sponsorship for attending conferences from, has accepted lecture fees from, or has been on advisory boards or provided consultancy for, the following companies; Altana Pharma, AZ, BI, GSK, MEDA Pharmaceuticals, MSD, Chiesi, Novartis and Schering Plough.
IS has recieved honouraria and support to attend international meetings from GSK, AZ, BI/Pfizer, Nycomed, TEVA and Chiesi. He is a trainer for Education for Health.
Comment in
-
Spirometry performance in primary care: the problem, and possible solutions.Prim Care Respir J. 2009 Sep;18(3):128-9. doi: 10.4104/pcrj.2009.00057. Prim Care Respir J. 2009. PMID: 19722100 Free PMC article. No abstract available.
-
Spirometry in primary care.Prim Care Respir J. 2009 Dec;18(4):239-40. doi: 10.4104/pcrj.2009.00065. Prim Care Respir J. 2009. PMID: 19921076 Free PMC article. No abstract available.
-
FEV1 and FVC repeatability goals when performing spirometry.Prim Care Respir J. 2010 Jun;19(2):194. doi: 10.4104/pcrj.2010.00031. Prim Care Respir J. 2010. PMID: 20467719 Free PMC article. No abstract available.
-
Recommendations on repeatability of spirometry.Prim Care Respir J. 2010 Jun;19(2):192; author reply 193. doi: 10.4104/pcrj.2010.00026. Prim Care Respir J. 2010. PMID: 20467720 Free PMC article. No abstract available.
-
Conflicting standards for diagnostic spirometry within-session repeatability are confusing.Prim Care Respir J. 2012 Jun;21(2):136. doi: 10.4104/pcrj.2012.00044. Prim Care Respir J. 2012. PMID: 22623049 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources